Alessia Romagnoli

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 11

Top Topics

Artificial Intelligence

Clinical Practice

Major Depressive Disorder

Small Cell Lung Cancer

Top Venues

European journal of clinical pharmacology

Pharmaceutical research

International journal of clinical practice

European journal of hospital pharmacy : science and practice

This page only lists publications with an associated author ORCID identifier.

Publications

Alessia Romagnoli, Andrea Zovi, Fiorenzo Santoleri, Ruggero Lasala
Antidepressant deprescribing: State of the art and recommendations-A literature overview. European journal of clinical pharmacology (2024)
Ruggero Lasala, Alessia Romagnoli, Fiorenzo Santoleri, Valentina Isgrò, Corrado Confalonieri, Alberto Costantini, Fiorenza Enrico, Gianluca Russo, Piera Polidori, Alessandra Di Paolo, Francesco Malorgio, Giordano Beretta, Felice Musicco
The lack of head-to-head randomised trials and the consequences for patients and national health service: The case of non-small cell lung cancer. European journal of clinical pharmacology 80 (4) (2024)
Alessia Romagnoli, Andrea Zovi, Fiorenzo Santoleri, Ruggero Lasala
Antidepressant deprescribing: State of the art and recommendations-A literature overview. European journal of clinical pharmacology 80 (3) (2024)
Alessia Romagnoli, Francesco Ferrara, Roberto Langella, Andrea Zovi
Healthcare Systems and Artificial Intelligence: Focus on Challenges and the International Regulatory Framework. Pharmaceutical research 41 (4) (2024)
Alessia Romagnoli, Francesco Ferrara, Roberto Langella, Andrea Zovi
Healthcare Systems and Artificial Intelligence: Focus on Challenges and the International Regulatory Framework. Pharmaceutical research 41 (4) (2024)
Ruggero Lasala, Alessia Romagnoli, Fiorenzo Santoleri, Valentina Isgrò, Corrado Confalonieri, Alberto Costantini, Fiorenza Enrico, Gianluca Russo, Piera Polidori, Alessandra Di Paolo, Francesco Malorgio, Giordano Beretta, Felice Musicco
The lack of head-to-head randomised trials and the consequences for patients and national health service: The case of non-small cell lung cancer. European journal of clinical pharmacology 80 (4) (2024)
Alessia Romagnoli, Andrea Zovi, Fiorenzo Santoleri, Ruggero Lasala
Antidepressant deprescribing: State of the art and recommendations-A literature overview. European journal of clinical pharmacology 80 (3) (2024)
Ruggero Lasala, Alessia Romagnoli, Fiorenzo Santoleri, Valentina Isgrò, Corrado Confalonieri, Alberto Costantini, Fiorenza Enrico, Gianluca Russo, Piera Polidori, Alessandra Di Paolo, Francesco Malorgio, Giordano Beretta, Felice Musicco
The lack of head-to-head randomised trials and the consequences for patients and national health service: The case of non-small cell lung cancer. European journal of clinical pharmacology (2024)
Alessia Romagnoli, Francesco Ferrara, Roberto Langella, Andrea Zovi
Healthcare Systems and Artificial Intelligence: Focus on Challenges and the International Regulatory Framework. Pharmaceutical research (2024)
Alessia Romagnoli, Fiorenzo Santoleri, Alberto Costantini, Angelora Di Risio
Adherence, persistence and switching rates of apixaban, dabigatran and rivaroxaban in non-valvular atrial fibrillation: a multicentre real-life analysis at 3 years. European journal of hospital pharmacy : science and practice (2022)
Alessia Romagnoli, Fiorenzo Santoleri, Alberto Costantini
Drug utilisation pattern over 3 years in the real-world treatment of type II diabetes. International journal of clinical practice 75 (6) (2021)